TGF-βファミリー濃度を用いたニボルマブ治療有効性の予測モデルの確立

• Project/Area Number: 22H04314
• Research Category: Grant-in-Aid for Encouragement of Scientists
• Allocation Type: Single-year Grants
• Review Section: 3180:Clinical pharmacy-related
• Research Institution: Hamamatsu University School of Medicine
• Principal Investigator: 阿部 一樹 浜松医科大学, 医学部附属病院, 薬剤師
• Project Period (FY): 2022-04-01 – 2023-03-31
• Project Status: Declined (Fiscal Year 2022)
• Budget Amount: ¥480,000 (Direct Cost: ¥480,000); Fiscal Year 2022: ¥480,000 (Direct Cost: ¥480,000)